US › Healthcare

Avita Medical Ltd (RCEL)

US · Healthcare · Medical Devices

$4.63+0.22%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$19.3M
Revenue YoY
+4.0%
Net profit
$-10.6M
Profit YoY
+23.4%
EPS
$-0.48
EPS estimate
$-0.38
Net margin
-55.1%

EPS came in at -0.48 against a street estimate of -0.38 — a miss of 26.3%.

Key statistics

Market cap
$135.4M
Forward P/E
10.3
P/B
11.77
Book value
$-0.75
EPS (TTM)
$-1.57
52-week high
$7.12
52-week low
$3.22
50-day MA
$4.38
200-day MA
$4.17
Beta
1.86

Analyst view

Analysts rate Avita Medical Ltd a strong buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $9.11.

Shareholding

Insiders
1.52%
Institutions
16.88%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC4.34%
BlackRock Inc3.68%
Geode Capital Management, LLC1.76%
State Street Corp1.39%
Vanguard Fiduciary Trust Co0.63%
Northern Trust Corp0.60%
Morgan Stanley - Brokerage Accounts0.51%
Divisadero Street Capital Management, LP0.32%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Avita Medical Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.